1 Min Read
May 18 (Reuters) - Medtronic Plc
* Medtronic resolute onyx(tm) 2.0 mm clinical study meets primary endpoint in extra-small vessels at one-year Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.